Fundz

Treace Secures Up To $150 Million In Debt Financing

PUBLIC · TMCIMay 02, 2022

Amount Raised

$150 Million

Round Type

Debt Financing

Ponte VedraManufacturingBiotechnologyHealthcareHealth CareMedicalMedical Device

Description

Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced that it has entered into a new five-year $150 million loan arrangement with MidCap Financial, comprising up to $120 million in term loans and a $30 million revolving credit facility. Proceeds from the new term loan refinanced the Company’s existing $30 million term loan from CR Group LP. In addition, the new revolving credit facility will expand the Company’s revolving credit capacity and replace the undrawn existing $10 million revolving credit facility from Silicon Valley Bank.

Quick answer

Treace raised $150 Million in a Debt Financing round, dated May 2, 2022. Treace is based in Ponte Vedra, Florida, United States.

How much did Treace raise?
Treace raised $150 Million in a Debt Financing round on May 2, 2022.
What does Treace do?
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction.
Where is Treace based and how big is it?
Treace is based in Ponte Vedra, Florida, United States.
Who are the decision-makers at Treace?
Fundz holds 1 contact at Treace. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Treace that raised within 45 days of this round, from Fundz verified event records.

  • Sanara MedTech raised $14M on June 2, 2022.
  • ENDRA Life Sciences raised $8.7M (Post-IPO Equity) on April 21, 2022.
  • Candesant Biomedical, Inc. raised $35M on April 12, 2022.
  • Flyte raised $75K (Seed) on March 31, 2022.
  • Harvard Apparatus Regenerative Technology raised $5.1M on June 8, 2022.
  • Rockwell Medical raised $15M (Funding Round) on June 7, 2022.

Who to call at Treace, and when

A new round usually means Treace is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Treace raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Treace, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Treace. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Treace

Location

Ponte Vedra, Florida, United States

About

Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Treace raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts16 people are listed at Treace. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Treace's next move

See what Strategic adds

Treace raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.